(Press-News.org) A growing recognition of the health impact of social risks – such as food insecurity and homelessness – has prompted researchers, healthcare providers and policymakers to consider ways to address these risk factors as part of holistic clinical care. However, some healthcare providers worry the same interventions designed to help patients and families with social risks might also make them feel singled out or like they are otherwise stigmatized.
Now, new results of a rigorous study from the University of Chicago Medicine published October 2023 in JAMA Pediatrics suggest well-designed interventions that address social risks can be provided to parents of hospitalized children without increasing self-reported experiences of discrimination.
The researchers said they hope these new findings will have the potential to remove a roadblock that has been holding back the field of social care research.
“What encouraged us to conduct this study is the combination of data from other studies showing that addressing social risks in clinical care can improve health and wellness, and patients and their families are amenable to receiving these kinds of interventions. However, studies also find clinicians consistently express concerns about compromising satisfaction and engendering feelings of discrimination when addressing social risks in clinical practice,” said Nathaniel Glasser, MD, an internist, pediatrician and health researcher at UChicago Medicine and lead author of the paper.
In the study, caregivers of pediatric patients were randomized to receive either usual care or usual care plus CommunityRx: a low-intensity, universally-delivered program that involves providing personalized information about local resources that help address social risks, such as food insecurity or transportation difficulties. After children were discharged from inpatient units, their parents filled out standardized surveys designed to assess their satisfaction with medical care and whether or not they experienced discrimination of any kind, such as being treated with less courtesy than others, during their child’s most recent hospital stay.
The researchers were able to conclude that CommunityRx did not increase experiences of discrimination, although some caregivers did report experiencing at least one form of discrimination during a hospital visit.
The team emphasized that discrimination in healthcare settings is a pervasive and well-documented issue that must be addressed, but clarified that this particular study focused on addressing social risks with root causes that lie outside the clinical setting, but to do so without making families feel stigmatized.
“Our intervention was not specifically designed to reduce experiences of discrimination that might happen during a child’s hospitalization; it was designed to reduce social risks families had when their child was admitted to the hospital,” said senior author Jennifer Makelarski, PhD, an epidemiologist and researcher at UChicago. “We wanted to make sure we're not causing harm – causing experiences of discrimination – by addressing social risks. With findings from this study, we are working toward an intervention that could do both.”
While parents in the study generally reported high satisfaction with medical care, the data didn’t offer a definitive conclusion about whether CommunityRx affected caregivers’ satisfaction with their experience during their child's hospital discharge, leaving the door open for further investigation. In particular, Makelarski said an ongoing qualitative study will help researchers better understand the intricate factors contributing to satisfaction and whether or not discharge is the best time to address social risks.
Makelarski noted that policymakers have already begun responding to a growing awareness of the importance of assessing and addressing social risks. Programs such as Medicare have already begun implementing strategies to incorporate these priorities into patient care, but until now they have been doing so with very little information about potential negative impacts. Insights from the current study indicate these efforts can continue, as long as they are implemented with caution, sensitivity and careful design.
“As a researcher, I think our results are a good sign that we should keep working on interventions that address social risks during clinical care; we should keep testing different variations,” Makelarski said.
She emphasized the importance of including a wide range of collaborators in the development of these interventions, including patients and community members.
“From a clinician’s perspective, ad hoc requests for resources to address social risks come up multiple times a day, but it’s not something most clinicians are trained to provide,” added Glasser. “Our findings suggest a low-cost, highly scalable intervention can be made widely available to patients, and clinicians can have some assurance that it can be done in a way that won't engender feelings of discrimination and stigma.”
The study, “CommunityRx-Hunger: A double-blind, randomized controlled trial examining noninferiority of a social care intervention on healthcare experiences,” was conducted with input from community advisors and published in JAMA Pediatrics in October 2023. Study co-authors include Stacy Tessler Lindau, Kristen Wroblewski, Emily M. Abramsohn, Deborah L. Burnet, Charles M. Fuller, Doriane C. Miller, Christine A. O’Malley, Eva Shiu and Elaine Waxman.
END
Clinical intervention directed at social risks does not increase experiences of discrimination
2023-11-02
ELSE PRESS RELEASES FROM THIS DATE:
$13M NIH grant funds research aimed at revitalizing immune systems of older adults
2023-11-02
University of Arizona Health Sciences researchers received a $13.1 million grant from the National Institute on Aging to continue studies aimed at rejuvenating the immune system of older people in order to improve health throughout the lifespan.
Older adults are disproportionally affected by infection, cancer and certain types of autoimmune disease. This is influenced by the fact that as a person ages, their body produces fewer T cells and gets less proficient at maintaining them. T cells are a type of white blood cell essential to the immune ...
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
2023-11-02
Type 1 diabetes is an autoimmune disease that causes the body's immune system to attack and destroy insulin-producing beta cells in the pancreas. Traditional management of type 1 diabetes has primarily involved replacing the missing insulin with injections which, though effective, can be expensive and burdensome. A new study led by researchers at the University of Chicago Medicine and Indiana University suggests that an existing drug could be repurposed to treat type 1 diabetes, potentially reducing dependence on insulin as the sole treatment.
The research centers on a medication known as α-difluoromethylornithine (DFMO), which inhibits an enzyme that plays a key role in cellular ...
New branch of oncology, cancer neuroscience, offers hope for hard-to-treat brain tumors
2023-11-02
Cancer cells hijack normal biological processes, allowing them to multiply. For example, tumors spur construction of new blood vessels, building themselves “highways” to supply nutrients.
Researchers have known about cancer’s blood vessel infiltration for decades, but it was only in the past few years that Stanford Medicine scientists and their colleagues discovered that tumors don’t just tap the body’s highway system; they can also infiltrate and exploit its “telecommunications.”
To ...
Less physical activity in adolescence likely rooted in biology
2023-11-02
AURORA, Colo. (Nov. 1, 2023) – The slowdown of physical activity during adolescence is not likely caused by lifestyle and environment but by energy demands placed on the body as it grows and sexually matures, according to a new study by researchers at the University of Colorado Anschutz Medical Campus.
The study, published today in the Proceedings of the Royal Society B, examined the lifestyles of the physically active Tsimane people, an indigenous population of forager-horticulturalists in lowland Bolivia, to see similarities and differences to adolescents living in post-industrialized nations.
“We wanted to look at the role of environment and the role of biology,” ...
Adult coral can handle more heat and keep growing thanks to heat-evolved symbionts
2023-11-02
Adult fragments of a coral species can better tolerate bleaching and recover faster when treated with tougher heat-evolved symbionts, new research from the Australian Institute of Marine Science (AIMS) and the University of Melbourne indicates.
The study also found that treatment with the heat-evolved symbionts did not compromise the coral’s ability to grow. This differs from previous studies on Great Barrier Reef corals which found that naturally heat tolerant symbionts could enhance heat resistance in adult corals, but at a cost to its growth.
Symbionts are the tiny cells of algae that live inside the coral tissue, providing corals with energy to grow. The survival ...
Stronger, stretchier, self-healing plastic
2023-11-02
An innovative plastic, stronger and stretchier than the current standard type and which can be healed with heat, remembers its shape and partially biodegradable, has been developed by researchers at the University of Tokyo. They created it by adding the molecule polyrotaxane to an epoxy resin vitrimer, a type of plastic. Named VPR, the material can hold its form and has strong internal chemical bonds at low temperatures. However, at temperatures above 150 degrees Celsius, those bonds recombine and the material can be reformed into different shapes. Applying heat and a solvent breaks VPR down into its raw components. Submerging it in seawater ...
Brain health in over 50s deteriorated more rapidly during the pandemic
2023-11-02
rain health in over 50s deteriorated more rapidly during the pandemic, even if they didn’t have COVID-19, according to major new research linking the pandemic to sustained cognitive decline.
Researchers looked at results from computerised brain function tests from more than 3,000 participants of the online PROTECT study, who were aged between 50 and 90 and based in the UK. The remote study, led by teams at the University of Exeter and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s ...
Low Emission Zones improve air quality, health, and people’s well-being – new policy brief
2023-11-02
The introduction of London's Low Emission Zone (LEZ) in 2008 and subsequent Ultra-Low Emission Zone (ULEZ) from 2019 has significantly improved air quality, benefiting Londoners’ physical and mental health, according to new analysis from the Department of Economics at the University of Bath.
A new Institute for Policy Research (IPR) policy brief, presenting research from health economists at the University, indicates that the introduction of the LEZ helped to reduce particulate matter (PM10) in Greater London by 13% between 2008-13, compared to pre-LEZ levels (2003-07).
The ULEZ has had an even more substantial impact, ...
An MRI-equipped ambulance: A game-changer for stroke care?
2023-11-02
In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14 seconds, according to the Centers for Disease Control and Prevention. When it comes to stroke, experts echo the fact that time is brain. Faster treatment translates to better outcomes, and certain treatments, like the clot-busting drug tPA, have a strict time window for administration.
“The quicker that we can get the patient to treatment, the quicker we can have a good outcome,” said Dustin LeBlanc, M.D., director of Prehospital Medicine and associate chief medical officer for Emergency Management at the Medical University of South Carolina (MUSC). ...
Repurposed drug offers new potential for managing type 1 diabetes
2023-11-01
INDIANAPOLIS -- A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The researchers’ findings, published in Cell Reports Medicine, suggest repurposing of the drug α-difluoromethylornithine (DFMO) may open doors to innovative therapies in the future.
Type 1 diabetes is a chronic condition wherein the body's immune system mistakenly ...